l-DOPA-Containing Protein Autoxidation: An Empirical Valence Bond Simulation of the Rate-Limiting Step

Area of Science:

• Biochemistry
• Neuroscience
• Computational Chemistry

Background:

• Parkinson's disease affects millions globally, with levodopa (l-DOPA) as a primary treatment.
• l-DOPA, while effective for motor symptoms, can lead to concerning long-term side effects.
• l-DOPA can undergo autoxidation, generating reactive oxygen species and contributing to oxidative stress.

Purpose of the Study:

• To investigate the mechanisms of l-DOPA-induced oxidative stress.
• To compute the free-energy profiles of l-DOPA reactions using computational methods.
• To compare the autoxidation rates of l-DOPA in solution and within proteins.

Main Methods:

• Empirical Valence Bond (EVB) method for free-energy profile computation.
• Modeling l-DOPA incorporated into Monoamine Oxidase A (MAO A).
• Analysis of rate-limiting steps in l-DOPA autoxidation and hydroxide ion transfer.

Main Results:

• Calculated activation barrier for l-DOPA in MAO A was 33.93 kcal mol⁻¹, higher than the experimental 27.55 kcal mol⁻¹ in solution.
• Autoxidation kinetics of l-DOPA-containing proteins appear slow.
• Oxidative stress may arise from l-DOPA in aqueous solution, its decarboxylation products, or metalloproteins.

Conclusions:

• The primary source of l-DOPA-induced oxidative stress is likely autoxidation in solution or subsequent dopamine autoxidation.
• Incorporation into proteins might not be the dominant pathway for oxidative stress.
• Zinc- and calcium-dependent proteins in the CNS represent a potential significant source of l-DOPA-induced oxidative stress.